HANSOH PHARMA Announces Appointment of New Joint Company Secretary and Authorized Representative

Stock News05-15

HANSOH PHARMA announced that Mr. Li Liangxian has resigned from his position as a joint company secretary of the company due to personal work arrangements. Concurrently, he will cease to serve as the company's authorized representative under Rule 3.05 of the Hong Kong Stock Exchange's Listing Rules, as well as the authorized representative for receiving legal process documents and notices in Hong Kong as required under Rule 19.05(2) of the Listing Rules and Part 16 of the Companies Ordinance. These changes are effective from May 15, 2026. Ms. Zeng Zhao has been appointed as the joint company secretary, authorized representative, and authorized representative for receiving legal process documents, effective from the same date, May 15, 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1168595314?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-15 21:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168595314","market":"us","top_or_hot":-1,"title":"HANSOH PHARMA Announces Appointment of New Joint Company Secretary and Authorized Representative","media":"Stock News","content":"<p>HANSOH PHARMA announced that Mr. Li Liangxian has resigned from his position as a joint company secretary of the company due to personal work arrangements. Concurrently, he will cease to serve as the company's authorized representative under Rule 3.05 of the Hong Kong Stock Exchange's Listing Rules, as well as the authorized representative for receiving legal process documents and notices in Hong Kong as required under Rule 19.05(2) of the Listing Rules and Part 16 of the Companies Ordinance. These changes are effective from May 15, 2026. Ms. Zeng Zhao has been appointed as the joint company secretary, authorized representative, and authorized representative for receiving legal process documents, effective from the same date, May 15, 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HANSOH PHARMA Announces Appointment of New Joint Company Secretary and Authorized Representative</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHANSOH PHARMA Announces Appointment of New Joint Company Secretary and Authorized Representative\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-15 21:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HANSOH PHARMA announced that Mr. Li Liangxian has resigned from his position as a joint company secretary of the company due to personal work arrangements. Concurrently, he will cease to serve as the company's authorized representative under Rule 3.05 of the Hong Kong Stock Exchange's Listing Rules, as well as the authorized representative for receiving legal process documents and notices in Hong Kong as required under Rule 19.05(2) of the Listing Rules and Part 16 of the Companies Ordinance. These changes are effective from May 15, 2026. Ms. Zeng Zhao has been appointed as the joint company secretary, authorized representative, and authorized representative for receiving legal process documents, effective from the same date, May 15, 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"","article_id":"1168595314","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168595314","pubTimestamp":1778850495,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"HANSOH PHARMA announced that Mr. Li Liangxian has resigned from his position as a joint company secretary of the company due to personal work arrangements. Concurrently, he will cease to serve as the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1583":"高瓴概念","BK1191":"制药","BK1589":"北水核心资产","03692":"翰森制药"},"translate_title":"翰森制药宣布委任新联席公司秘书及授权代表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03692":1},"content_text":"HANSOH PHARMA announced that Mr. Li Liangxian has resigned from his position as a joint company secretary of the company due to personal work arrangements. Concurrently, he will cease to serve as the company's authorized representative under Rule 3.05 of the Hong Kong Stock Exchange's Listing Rules, as well as the authorized representative for receiving legal process documents and notices in Hong Kong as required under Rule 19.05(2) of the Listing Rules and Part 16 of the Companies Ordinance. These changes are effective from May 15, 2026. Ms. Zeng Zhao has been appointed as the joint company secretary, authorized representative, and authorized representative for receiving legal process documents, effective from the same date, May 15, 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1168595314","isCrawlerRequest":true}